Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
18.41
-0.02 (-0.11%)
Aug 22, 2025, 3:00 PM CST
SHA:603456 Revenue
Zhejiang Jiuzhou Pharmaceutical had revenue of 1.38B CNY in the quarter ending June 30, 2025, with 7.15% growth. This brings the company's revenue in the last twelve months to 5.27B, up 4.65% year-over-year. In the year 2024, Zhejiang Jiuzhou Pharmaceutical had annual revenue of 5.16B, down -6.57%.
Revenue (ttm)
5.27B
Revenue Growth
+4.65%
P/S Ratio
3.08
Revenue / Employee
1.05M
Employees
5,001
Market Cap
16.23B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.16B | -362.83M | -6.57% |
Dec 31, 2023 | 5.52B | 78.31M | 1.44% |
Dec 31, 2022 | 5.45B | 1.38B | 34.01% |
Dec 31, 2021 | 4.06B | 1.42B | 53.48% |
Dec 31, 2020 | 2.65B | 630.47M | 31.26% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 41.90B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Sichuan Biokin Pharmaceutical | 441.19M |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |